Data-driven identification of structural alerts for mitigating the risk of drug-induced human liver injuries

被引：0
|
作者：
Ruifeng Liu
Xueping Yu
Anders Wallqvist
机构：
[1] U.S. Army Medical Research and Materiel Command,Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center
来源：
Journal of Cheminformatics | / 7卷
关键词：
Drug-induced liver injury; Hepatotoxicity; Structure alert; Bioactivation; Reactive metabolite;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Risk Factors for Idiosyncratic Drug-Induced Liver Injury
    Chalasani, Naga
    Bjornsson, Einar
    [J]. GASTROENTEROLOGY, 2010, 138 (07) : 2246 - 2259
  • [22] Incidence and risk factors of drug-induced liver injury
    Li, Xiaoyun
    Tang, Jieting
    Mao, Yimin
    [J]. LIVER INTERNATIONAL, 2022, 42 (09) : 1999 - 2014
  • [23] ZELBORAF (vemurafenib): risk of drug-induced liver injury
    [J]. Reactions Weekly, 2014, 1497 (1) : 3 - 3
  • [24] In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries
    Utkarsh, Doshi
    Loretz, Carol
    Li, Albert P.
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2016, 255 : 12 - 22
  • [25] Drug-induced liver injury.: Eleventh updated edition of the bibliographic data base of liver injuries and related drugs
    Biour, M
    Poupon, R
    Grangé, JD
    Chazouillères, O
    Jaillon, P
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1998, 22 (12): : 1004 - 1044
  • [26] Identification of in silico structural alerts for liver steatosis induced by nuclear receptor agonists
    Mellor, Claire
    Cronin, Mark
    Steinmetz, Fabian
    [J]. TOXICOLOGY LETTERS, 2014, 229 : S162 - S162
  • [27] Data-driven structural identification of nonlinear assemblies: Uncertainty Quantification
    Safari, Sina
    Montalvão, Diogo
    Monsalve, Julián M. Londoño
    [J]. International Journal of Non-Linear Mechanics, 2025, 170
  • [28] The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development
    Walker, Paul A.
    Ryder, Stephanie
    Lavado, Andrea
    Dilworth, Clive
    Riley, Robert J.
    [J]. ARCHIVES OF TOXICOLOGY, 2020, 94 (08) : 2559 - 2585
  • [29] The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development
    Paul A. Walker
    Stephanie Ryder
    Andrea Lavado
    Clive Dilworth
    Robert J. Riley
    [J]. Archives of Toxicology, 2020, 94 : 2559 - 2585
  • [30] Risk assessment of drug-induced liver injury based on in vitro covalent binding to human liver proteins
    Usui, Toru
    Mise, Masashi
    Hashizume, Takanori
    Yabuki, Masashi
    Komuro, Setsuko
    [J]. DRUG METABOLISM REVIEWS, 2009, 41 : 125 - 125
12345